January 2021

Chin J, Zhou Y, Chen CL, Lomiguen CM, McClelland S, Lee-Wong M. Influenza Vaccination Quality Improvement as a Model for COVID-19 Prophylaxis. Cureus. 2021;13(1):e12549. Published 2021 Jan 7. doi:10.7759/cureus.12549
Full text

Kassianos G, Banerjee A, Baron-Papillon F, et al. Key policy and programmatic factors to improve influenza vaccination rates based on the experience from four high-performing countries. Drugs Context. 2021;10:2020-9-5. Published 2021 Jan 5. doi:10.7573/dic.2020-9-5
Full text

Kumar S, Xu C, Ghildayal N, Chandra C, Yang M. Social media effectiveness as a humanitarian response to mitigate influenza epidemic and COVID-19 pandemic [published online ahead of print, 2021 Jan 29]. Ann Oper Res. 2021;1-29. doi:10.1007/s10479-021-03955-y
Full text

Li P, Hayat K, Jiang M, et al. Impact of video-led educational intervention on the uptake of influenza vaccine among adults aged 60 years and above in China: a study protocol for a randomized controlled trial. BMC Public Health. 2021;21(1):222. Published 2021 Jan 27. doi:10.1186/s12889-021-10220-1
Full text

McMillan CLD, Young PR, Watterson D, Chappell KJ. The Next Generation of Influenza Vaccines: Towards a Universal Solution. Vaccines (Basel). 2021;9(1):26. Published 2021 Jan 7. doi:10.3390/vaccines9010026
Full text

Schmader KE, Liu CK, Harrington T, et al. Safety, Reactogenicity, and Health-Related Quality of Life After Trivalent Adjuvanted vs Trivalent High-Dose Inactivated Influenza Vaccines in Older Adults: A Randomized Clinical Trial. JAMA Netw Open. 2021;4(1):e2031266. Published 2021 Jan 4. doi:10.1001/jamanetworkopen.2020.31266
Full text

Shi X, Chen M, Zhang Y. The cardiovascular disorders and prognostic cardiac biomarkers in COVID-19 [published online ahead of print, 2021 Jan 22]. Mol Biol Rep. 2021;1-9. doi:10.1007/s11033-021-06148-9
Full text

Sparrow E, Wood JG, Chadwick C, et al. Global production capacity of seasonal and pandemic influenza vaccines in 2019. Vaccine. 2021;39(3):512-520. doi:10.1016/j.vaccine.2020.12.018
Full text

Wiemken TL, Rutschman AS. Development of vaccines for influenza disease: Opportunity costs of the COVID-19 pandemic. Vaccine. 2021;39(7):1025-1026. doi:10.1016/j.vaccine.2021.01.014
Full text

Zhang C, Cui H, Wang Z, et al. Pathogenicity and transmissibility assessment of two strains of human influenza virus isolated in China in 2018. J Int Med Res. 2021;49(1):300060520982832. doi:10.1177/0300060520982832
Full text

Zhu W, Dong C, Wei L, Wang BZ. Promising Adjuvants and Platforms for Influenza Vaccine Development. Pharmaceutics. 2021;13(1):68. Published 2021 Jan 7. doi:10.3390/pharmaceutics13010068
Full text

 

December 2020

Chen X, Wang W, Wang Y, et al. Serological evidence of human infections with highly pathogenic avian influenza A(H5N1) virus: a systematic review and meta-analysis. BMC Med. 2020;18(1):377. Published 2020 Dec 2. doi:10.1186/s12916-020-01836-y
Full text

Khan MS, Shahid I, Stefan D, Anker SD. et al. Cardiovascular implications of COVID-19 versus influenza infection: a review. BMC Med. 2020; 18: 403.  Published online 2020 Dec 18. doi: 10.1186/s12916-020-01816-2
Full text

Lu L, Fong CH, Zhang AJ, et al. Repurposing of Miltefosine as an Adjuvant for Influenza Vaccine. Vaccines (Basel). 2020;8(4):754. Published 2020 Dec 11. doi:10.3390/vaccines8040754
Full text

Mudd PA, Crawford JC, Turner JS, et al. Distinct inflammatory profiles distinguish COVID-19 from influenza with limited contributions from cytokine storm. Sci Adv. 2020;6(50):eabe3024. Published 2020 Dec 9. doi:10.1126/sciadv.abe3024
Full text

Olsen SJ, Azziz-Baumgartner E, Budd AP, et al. Decreased influenza activity during the COVID-19 pandemic-United States, Australia, Chile, and South Africa, 2020. Am J Transplant. 2020;20(12):3681-3685. doi:10.1111/ajt.16381
Full text

Sharma Y, Horwood C, Hakendorf P, Thompson C. Clinical characteristics and outcomes of influenza A and B virus infection in adult Australian hospitalised patients. BMC Infect Dis. 2020; 20: 913. Published online 2020 Dec 1. doi: 10.1186/s12879-020-05670-8
Full text

Schumacher S, Salmanton-García J, Cornely OA, Mellinghoff SC. Increasing influenza vaccination coverage in healthcare workers: a review on campaign strategies and their effect [published online ahead of print, 2020 Dec 7]. Infection. 2020;1-13. doi:10.1007/s15010-020-01555-9
Full text

Zhao X, Gang X, He G, et al. Obesity Increases the Severity and Mortality of Influenza and COVID-19: A Systematic Review and Meta-Analysis. Front Endocrinol (Lausanne). 2020;11:595109. Published 2020 Dec 21. doi:10.3389/fendo.2020.595109
Full text

 

November 2020

Huang QS, Wood T, Jelley L, et al. Impact of the COVID-19 nonpharmaceutical interventions on influenza and other respiratory viral infections in New Zealand. Preprint. medRxiv. 2020;2020.11.11.20228692. Published 2020 Nov 13. doi:10.1101/2020.11.11.20228692
Full text

Li Y, Xiao Y, Chen Y, Huang K. Nano-based approaches in the development of antiviral agents and vaccines [published online ahead of print, 2020 Nov 12]. Life Sci. 2020;118761. doi:10.1016/j.lfs.2020.118761
Full text

Liu R, Liu X, Yang P, et al. Influenza-associated cardiovascular mortality in older adults in Beijing, China: a population-based time-series study. BMJ Open. 2020;10(11):e042487. Published 2020 Nov 19. doi:10.1136/bmjopen-2020-042487
Full text

Rockman S, Laurie KL, Parkes S, Wheatley A, Barr IG. New Technologies for Influenza Vaccines. Microorganisms. 2020;8(11):1745. Published 2020 Nov 6. doi:10.3390/microorganisms8111745
Full text

Sullivan SG, Carlson S, Cheng AC, et al. Where has all the influenza gone? The impact of COVID-19 on the circulation of influenza and other respiratory viruses, Australia, March to September 2020. Euro Surveill. 2020;25(47):2001847. doi:10.2807/1560-7917.ES.2020.25.47.2001847
Full text

Sunagawa S, Iha Y, Kinjo T, Nakamura K, Fujita J. Disappearance of summer influenza in the Okinawa prefecture during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic [published online ahead of print, 2020 Nov 16]. Respir Investig. 2020;S2212-5345(20)30161-1. doi:10.1016/j.resinv.2020.10.010
Full text

Yang K, Zhang N, Gao C, Qin H, Wang A, Song L. Risk factors for hospital-acquired influenza A and patient characteristics: a matched case-control study. BMC Infect Dis. 2020;20(1):863. Published 2020 Nov 19. doi:10.1186/s12879-020-05580-9
Full text

Zhu R, Chen C, Wang Q, Zhang X, Lu C, Sun Y. Routine blood parameters are helpful for early identification of influenza infection in children. BMC Infect Dis. 2020;20(1):864. Published 2020 Nov 19. doi:10.1186/s12879-020-05584-5
Full text

 

(Updated 16 February 2021)